Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2021-10-18 00:00:00 ET · period of report 2021-10-15 · accession 0001493152-21-025690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-18 | 2021-10-15 | ABEO | Seshadri Vishwas | CEO, Dir | A - Grant | $0.00 | +50.0K | 350.0K | +17% | $0 |
| D | 2021-10-18 | 2021-10-15 | ABEO | Seshadri Vishwas | CEO, Dir | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2021-10-15 | A | A | 50,000 | $0.00 | 350,000 | D | — | — | (F1) The restricted stock will vest 25% on each of October 15, 2022, October 15, 2023, October 15, 2024 and October 15, 2025. |
| 2 | Derivative | Stock Option (right to buy) | 2021-10-15 | A | A | 300,000 | $0.00 | 300,000 | D | $0.91 · — to 2031-10-15 | 300,000 Common Stock | (F2) The options will vest 25% on October 15, 2022, and in 36 equal monthly installments thereafter. |